Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EVFM | US
0
0%
Healthcare
Biotechnology
30/06/2024
08/06/2026
0.01
0.01
0.01
0.01
Evofem Biosciences Inc. a biopharmaceutical company develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences Inc. is headquartered in San Diego California.
View LessStrong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
144.9%1 month
146.5%3 months
122.1%6 months
110.4%0.00
-
8.37
-
-
-0.74
2.77
-
-11.09M
752.47K
752.47K
-
-33.39
-
69.20
-387.27
0.19
11.01
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.00
Range1M
0.00
Range3M
0.01
Rel. volume
0.07
Price X volume
75.16
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lipella Pharmaceuticals Inc. Common Stock | LIPO | Biotechnology | 0.1 | 810.46K | n/a | 5.50% | |
| CARM | CARM | Biotechnology | 0.019 | 789.35K | 18900.00% | n/a | 1044.17% |
| Galmed Pharmaceuticals Ltd | GLMD | Biotechnology | 0.4693 | 707.23K | -32.57% | n/a | 0.00% |
| Sorrento Therapeutics Inc | SRNE | Biotechnology | 0.0011 | 696.25K | 120.00% | n/a | -101.21% |
| Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 0.296 | 672.88K | 8.11% | n/a | 222.75% |
| Pasithea Therapeutics Corp. Common Stock | KTTA | Biotechnology | 0.5756 | 601.45K | -1.61% | n/a | 0.00% |
| IO Biotech Inc. Common Stock | IOBT | Biotechnology | 0.0085 | 559.99K | 3.66% | n/a | 2.23% |
| Arsanis Inc | ASNS | Biotechnology | 0.08 | 481.44K | 2.70% | n/a | 252.35% |
| Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 0.31 | 443.72K | -6.06% | 0.06 | 0.00% |
| Hepion Pharmaceuticals Inc | HEPA | Biotechnology | 0.061 | 353.75K | n/a | 4.33% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0058 | 534.84K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4181 | 230.37K | 7.87% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.74 | 0.53 | Cheaper |
| Ent. to Revenue | 2.77 | 3,967.00 | Cheaper |
| PE Ratio | 0.00 | 41.03 | Cheaper |
| Price to Book | 8.37 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 122.07 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 752.47K | 3.66B | Emerging |